High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

Skin biopsy specimens of three lesions on her back were consistent with cutaneous T-cell lymphoma (CTCL). On physical examination, she had erythematous patches and plaques with ill-defined borders ...

FOXP3 + regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 21 , 2512–2518 (2007). Article CAS PubMed Google Scholar ...

It is being tested in clinical trials for cutaneous T-cell lymphoma (CTCL ... with key secondary endpoints including ...

Blood flow cytometry confirmed an abnormal T-cell population. These findings were suggestive of T-cell lymphoma. Serologies for tuberculosis, hepatitis, HIV, human T-lymphotropic virus type 1 or 2, ...